Ella A Kazerooni
Overview
Explore the profile of Ella A Kazerooni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
270
Citations
9957
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lancaster H, Walstra A, Myers K, Avila R, Gratama J, Heuvelmans M, et al.
Eur J Cancer
. 2025 Mar;
220:115323.
PMID: 40022837
Reduction in lung cancer mortality is achievable through low dose computed tomography (LDCT) screening in high-risk individuals. Many countries are progressing from local LDCT screening studies to national screening programs....
2.
Mulshine J, Pyenson B, Healton C, Aldige C, Avila R, Blum T, et al.
Eur J Cancer
. 2025 Feb;
218:115264.
PMID: 39904127
Large-scale lung cancer screening implementation combined with improvements in early detection techniques for three major tobacco-related diseases presents a rare opportunity to markedly improve population health outcomes for millions of...
3.
Tammemagi M, Borondy-Kitts A, Field J, Henschke C, Mohan A, Kerpel-Fronius A, et al.
J Thorac Oncol
. 2025 Jan;
PMID: 39864549
Introduction: Lung cancer screening (LCS) using low-dose-computed tomography reduces lung cancer mortality in high-risk individuals. Evaluating and monitoring LCS programs are important to ensure and improve quality, efficiency and participant...
4.
Wood D, Kazerooni E, Aberle D, Argento C, Baines J, Boer B, et al.
J Natl Compr Canc Netw
. 2025 Jan;
23(1.
PMID: 39819601
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Lung Cancer Screening provide criteria for selecting individuals for screening and offer recommendations for evaluating and managing lung nodules detected...
5.
Konopka K, Kazerooni E, Han M, Myers J
Am J Surg Pathol
. 2025 Jan;
PMID: 39815602
Proliferations of neoplastic perivascular epithelioid cells (PECs) may occur within the lung and extrathoracic sites. The term "PEComatosis" is applied to multiple or diffuse microscopic proliferations of neoplastic PECs. Pulmonary...
6.
Huber R, Lam S, Cavic M, Balata H, Kitts A, Field J, et al.
J Thorac Oncol
. 2025 Jan;
20(1):e6-e8.
PMID: 39794116
No abstract available.
7.
Lockstadt C, Pasquinelli M, Feldman J, Studts J, Ostroff J, Liu L, et al.
JTO Clin Res Rep
. 2025 Jan;
6(1):100711.
PMID: 39758597
Introduction: In 2021, the International Association for the Study of Lung Cancer (IASLC) published the IASLC Language Guide as guidance on preferred language and phrasing in oral and written communications,...
8.
Fathi J, Barry A, Greenberg G, Henschke C, Kazerooni E, Kim J, et al.
Cancer
. 2024 Sep;
130(23):3961-3972.
PMID: 39302235
More than a decade has passed since researchers in the Early Lung Cancer Action Project and the National Lung Screening Trial demonstrated the ability to save lives of high-risk individuals...
9.
Lewis J, Klein D, Eberth J, Carter-Bawa L, Studts J, Tong B, et al.
Cancer
. 2024 Sep;
130(23):3973-3984.
PMID: 39302232
The American Cancer Society National Lung Cancer Roundtable strategic plan for provider engagement and outreach addresses barriers to the uptake of lung cancer screening, including lack of provider awareness and...
10.
Kazerooni E, Wood D, Rosenthal L, Smith R
Cancer
. 2024 Sep;
130(23):3948-3960.
PMID: 39302215
Lung cancer is the leading cause of cancer death in the United States and across the world. The American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) was established in...